GlaxoSmithKline plc proposed acquisition of the consumer healthcare business of Pfizer Inc

Acquirer(s)

  • GlaxoSmithKline plc

Target(s)

  • Consumer healthcare business of Pfizer Inc

Summary

Proposed acquisition of  Pfizer Inc's Consumer Healthcare Business by GlaxoSmithKline plc.

Market inquiries

Submissions are invited from interested parties regarding the proposed acquisition of Pfizer Inc's Consumer Healthcare Business by GlaxoSmithKline plc by 13 March 2019.

Submissions should be forwarded electronically (preferably in PDF format) to mergers@accc.gov.au with the title: “Submission re: proposed acquisition of Pfizer Inc's Consumer Healthcare Business by GlaxoSmithKline plc  - attention Nigel Vise and Yong Xu.” Alternatively submissions may be mailed to the Merger Investigations Branch, ACCC, GPO Box 3131
Canberra ACT 2601.

Following 13 March 2019 queries regarding the ACCC's review may be addressed to Nigel Vise or Yong Xu at mergers@accc.gov.au. For more details, please refer to the attached market inquiries letter.
 

Market inquiries

Timeline

DateEvent
27/02/2019ACCC commenced informal review under the Informal Merger Review Process Guidelines.
13/03/2019Closing date for submissions.
17/04/2019ACCC is awaiting further information from third parties. Former provisional decision date of 25 April 2019 delayed. ACCC will announce a proposed decision date in due course.

Project staff

  • Nigel Vise
  • Yong Xu

Contact email